|Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogene|
M Tanic, K Yanowsky, C Rodriguez-Antona, R Andrés, I Márquez-Rodas, ...
PloS one 7 (6), e38847, 2012
|Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway|
M Tanic, M Zajac, G Gómez-López, J Benítez, B Martínez-Delgado
Breast Cancer Research and Treatment, 1-11, 2011
|MicroRNA expression signatures for the prediction of BRCA1/2 mutation‐associated hereditary breast cancer in paraffin‐embedded formalin‐fixed breast tumors|
M Tanic, K Yanowski, G Gómez‐López, M Socorro Rodriguez‐Pinilla, ...
International journal of cancer 136 (3), 593-602, 2015
|Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade|
B Martinez-Delgado, M Gallardo, M Tanic, K Yanowsky, L Inglada-Perez, ...
Breast cancer research and treatment 141 (2), 231-242, 2013
|MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours|
M Tanic, E Andres, SM Rodriguez-Pinilla, I Marquez-Rodas, ...
British journal of cancer 109 (10), 2724, 2013
|Neoantigen-directed immune escape in lung cancer evolution|
R Rosenthal, EL Cadieux, R Salgado, M Al Bakir, DA Moore, CT Hiley, ...
Nature 567 (7749), 479, 2019
|Epigenome-wide association studies for cancer biomarker discovery in circulating cell-free DNA: technical advances and challenges|
M Tanić, S Beck
Current opinion in genetics & development 42, 48-55, 2017
|miRNA expression profiling of formalin-fixed paraffin-embedded (FFPE) hereditary breast tumors|
M Tanić, K Yanowski, E Andrés, G Gómez-López, MRP Socorro, ...
Genomics data 3, 75-79, 2015
|Cell cycle, apoptosis, cellular uptake and whole-transcriptome microarray gene expression analysis of HeLa cells treated with a ruthenium (II)-arene complex with an …|
KK Jovanović, M Tanić, I Ivanović, N Gligorijević, BP Dojčinović, ...
Journal of inorganic biochemistry 163, 362-373, 2016
|Pharmacogenetics in cancer therapy-8 years of experience at the Institute for Oncology and Radiology of Serbia|
M Cavic, A Krivokuca, I Boljevic, K Brotto, K Jovanovic, M Tanic, ...
J BUON 21 (5), 1287-1295, 2016
|Quantification of tumour evolution and heterogeneity via Bayesian epiallele detection.|
S Barrett, J. E., Feber, A., Herrero, J., Tanic, M., Wilson, G. A., Swanton ...
BMC Bioinformatics 18 (1), 354-, 2017
|Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer|
M Tanić, A Krivokuća, M Čavić, J Mladenović, VP Karapandžić, S Beck, ...
Radiation Oncology 13 (1), 193, 2018
|Tumor response and patient outcome after preoperative radiotherapy in locally advanced non-inflammatory breast cancer patients|
J Mladenovic, S Susnjar, M Tanic, R Jankovic, K Karadzic, D Gavrilovic, ...
Journal of BU ON.: official journal of the Balkan Union of Oncology 22 (2 …, 2017
|Abstract P4-04-13: Could genes associated with response or resistance to radiotherapy be identified in breast cancer patients?|
J Mladenovic, S Susnjar, R Jankovic, M Tanic, S Radulovic, ...
Cancer Research 73 (24 Supplement), P4-04-13-P4-04-13, 2013
|PO-342 Integrating copy number analysis and tumour DNA methylation profiling|
EL Cadieux, G Wilson, M Tanic, J Demeulemeester, J Barrett, N Birkbak, ...
ESMO Open 3 (Suppl 2), A362-A362, 2018
|Cell-free DNA: Treasure trove for cancer medicine|
M Tanić, S Beck
Nature Materials 16 (11), 1056-1057, 2017
|Supplementary material for Quantification of tumour evolution and heterogeneity via Bayesian epiallele detection|
JE Barrett, A Feber, J Herrero, M Tanic, G Wilson, C Swanton, S Beck
|Multiregion sequencing of penile cancer to reveal distinct patterns of heterogeneous actionable mutations.|
S Rodney, M Tanic, J Barrett, WP Amy, P De Winter, WS Tan, P Khetrapal, ...
Journal of Clinical Oncology 35 (15_suppl), 4518-4518, 2017
|EpiCapture: Benchmarking commercially available targeted bisulfite-sequencing platforms to gold-standard whole genome bisulfite sequencing|
M Tanic, S Rodney, J Barrett, H Parker, A Feber, S Beck
Cancer Research 76 (14 Supplement), 4530-4530, 2016
|EGFR mutations in advanced non-small cell lung cancer patients in Serbia: 3 year-experience of central testing and gefitinib therapy response.|
R Jankovic, M Cavic, J Spasic, A Krivokuca, K Brotto, K Jovanovic, ...
Journal of Clinical Oncology 33 (15_suppl), e19111-e19111, 2015